Viatris Inc. (VTRS)
NASDAQ: VTRS · IEX Real-Time Price · USD
11.55
+0.19 (1.67%)
At close: Apr 24, 2024, 4:00 PM
11.54
-0.01 (-0.09%)
Pre-market: Apr 25, 2024, 8:02 AM EDT
Viatris Market Cap
Viatris has a market cap or net worth of $13.72 billion as of April 25, 2024. Its market cap has increased by 16.00% in one year.
Market Cap
13.72B
Enterprise Value
30.86B
1-Year Change
16.00%
Ranking
Category
Stock Price
$11.55
Market Cap Chart
Since December 1, 1998, Viatris's market cap has increased from $4.38B to $13.72B, an increase of 213.10%. That is a compound annual growth rate of 4.59%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2024 | 13.72B | 1.67% |
Apr 23, 2024 | 13.49B | 0.98% |
Apr 22, 2024 | 13.36B | - |
Apr 19, 2024 | 13.36B | 1.17% |
Apr 18, 2024 | 13.21B | 0.18% |
Apr 17, 2024 | 13.18B | -0.18% |
Apr 16, 2024 | 13.21B | -1.77% |
Apr 15, 2024 | 13.44B | -0.09% |
Apr 12, 2024 | 13.46B | -2.07% |
Apr 11, 2024 | 13.74B | -1.20% |
Apr 10, 2024 | 13.91B | -0.93% |
Apr 9, 2024 | 14.04B | 0.60% |
Apr 8, 2024 | 13.95B | -0.42% |
Apr 5, 2024 | 14.01B | 0.34% |
Apr 4, 2024 | 13.97B | -2.16% |
Apr 3, 2024 | 14.27B | 0.67% |
Apr 2, 2024 | 14.18B | - |
Apr 1, 2024 | 14.18B | - |
Mar 28, 2024 | 14.18B | 0.93% |
Mar 27, 2024 | 14.05B | 1.98% |
Mar 26, 2024 | 13.78B | -1.94% |
Mar 25, 2024 | 14.05B | -0.08% |
Mar 22, 2024 | 14.06B | -1.42% |
Mar 21, 2024 | 14.26B | 1.09% |
Mar 20, 2024 | 14.11B | 0.08% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Walgreens Boots Alliance | 15.27B |
Quest Diagnostics | 15.10B |
BeiGene | 14.85B |
Teva Pharmaceutical | 14.57B |
Neurocrine Biosciences | 13.84B |
Revvity | 12.64B |
Skye Bioscience | 12.57B |
Royalty Pharma | 12.38B |